Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 111 Neoplasm Metastasis 9 Neoplasms 5 Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms, Male 3 Breast Diseases 3 Obesity 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Breast Cancer Metastatic 2 Arthralgia 2 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Sleep Wake Disorders 1 Skin Diseases 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Prostatic Neoplasms 1 Primary Breast Cancer ER+ve 1 Post Menopausal Women With Early Breast Cancer 1 Patient Acceptance of Health Care 1 Pain 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Metastatic Beast Cancer 1 Mammary Neoplasms, Animal 1 Lymphoma 1 Lung Neoplasms 1 Lung Diseases 1 Lethal Congenital Contracture Syndrome 2 1

Interventions

exemestane 1 enzalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Primary Breast Cancer ER+ve × exemestane × Clear all

NCT02676986 2024-07-05

ARB

Queen Mary University of London

Phase 2 Completed

Primary Breast Cancer ER+ve

Data powered by HemOnc (CC BY 4.0) Colophon ⚡